title: Unusual manifestations of myelofibrosis in a patient with congenital asplenia.
authors: Department of Internal Medicine F, Assaf Harofeh Medical Center, Zerifin, Israel.
authors: Dorit
authors: D
authors: Almoznino-Sarafian
authors: Eynat
authors: E
authors: Dotan
authors: Judith
authors: J
authors: Sandbank
authors: Oleg
authors: O
authors: Gorelik
authors: Shulamit
authors: S
authors: Chachashvily
authors: Miriam
authors: M
authors: Shteinshnaider
authors: Natan
authors: N
authors: Cohen
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000000981:diagnostic imaging / Q000209:etiology; D004198:Disease Susceptibility; D004893:Erythema Nodosum / Q000209:etiology; D005335:Fever of Unknown Origin / Q000209:etiology; D006411:Hematopoiesis, Extramedullary; D006801:Humans; D007668:Kidney / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D011877:Radionuclide Imaging; D013154:Spleen / Q000002:abnormalities*; D014069:Tonsillitis / Q000150:complications / Q000188:drug therapy
chemical_list: D000900:Anti-Bacterial Agents; D011241:Prednisone